Germany: How are patents interpreted after nullity proceedings?

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Germany: How are patents interpreted after nullity proceedings?

judgment-image-final.jpg

In German patent law, the separation principle applies, according to which a patent claim is interpreted consistently in infringement and opposition, nullity and restriction proceedings. There is no mutual binding effect of decisions of the infringement or nullity courts, instead, each of the courts is responsible for determining the meaning of a patent claim, which is a legal question. For example, the grounds of a nullity decision on the maintenance of a patent with a restricted patent claim may serve as an interpretative aid for the infringement court. In principle, the currently valid version of a patent claim is relevant for its interpretation, and in the case of amendments in opposition or nullity or restriction proceedings, the amended version is therefore relevant. The subject matter of the patent claim is now determined by the wording of the restricted claim, as explained by the description and drawings in light of the grounds of the decision.

In the court decision 15 U 65/17, the Higher Regional Court (OLG) of Düsseldorf discussed a patent claim restricted in nullity proceedings before the Federal Patent Court (BPatG) regarding a urinary catheter set. For this patent, the description was not adapted to the restricted claim. This was of importance as the timing of the production of the low-friction surface character of the urinary catheter was disputed between the parties. According to the invention, a special coating was used in combination with a liquid swelling medium so that the low friction surface was able to glide through the walls of the urethra particularly easily. The claim required that this liquid swelling medium was accommodated in a storage body in a cavity. Due to a foreign reference, it was disputed between the parties whether the production of the low friction surface took place during production outside Germany or only by the user of the urinary catheter set in Germany. Passages of the original description, which was not amended in the nullity proceedings, also applied to embodiments. In these, the manufacturer of the urinary catheter set already achieves these effects.

The Higher Regional Court of Düsseldorf reversed the decision of the lower court. For the interpretation of the disputed feature, according to which the low friction surface character is made prior to use of the catheter, in the absence of an adaptation of the description, the grounds of the nullity decision had to be used as a supplement to the patent description. As a result, the disputed feature as interpreted does not allow the finding of a literal infringement of the patent.

Thomas Ederer

more from across site and SHARED ros bottom lb

More from across our site

The firm reveals how its litigation strategies informed the arguments that took Masimo’s judgment past $818 million
The firm was rebuilding its IP practice through a string of patent hires and a Texas expansion, but its dissolution has put the newly built talent back into the market
AI can exploit longstanding gaps in copyright protection at remarkable speed, but EU law still provides tools to fight back, says Simon Hembt at Bird & Bird
The firm has tapped a local patent trio to establish a foothold in the market and broaden its national presence
New Asia-Pacific IP head Jonathan Chu is eyeing opportunities arising from Chinese technology licensing, overseas enforcement and increasingly IP-heavy cross-border deals
Europe’s largest intellectual property convention and trade fair is back: IP Service World 2026 takes place in Munich from November 23–25 – the 16th edition, with 1,400-plus attendees from 55-plus nations, 100-plus speakers, and 100-plus exhibitors. Three days. Two focused areas. One IP marketplace.
Mehmet Gün and Uğur Aktekin discuss four decades of change in Türkiye’s legal market, the firm’s commitment to independence and the challenge of building an institution that can outlast its founders
Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
Gift this article